OQS
ORGO icon

Occudo Quantitative Strategies’s Organogenesis Holdings ORGO Stock Holding History

Occudo Quantitative Strategies’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52,426
Closed -$149K – 930
2024
Q1 		$149K Buy
+52,426
New +$178K 0.03% 624
2023
Q3 		– Sell
-76,549
Closed -$254K – 1218
2023
Q2 		$254K Buy
+76,549
New +$226K 0.03% 790
2021
Q1 		– Sell
-22,203
Closed -$167K – 884
2020
Q4 		$167K Buy
+22,203
New +$105K 0.05% 568

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Occudo Quantitative Strategies's ORGO Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 52,426 shares — an estimated $149K sold.

Occudo Quantitative Strategies first reported a position in ORGO in Q4 2020 and held it in 3 quarters. The position peaked at $254K in Q2 2023. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 52,426 Organogenesis Holdings shares in Q2 2024, an estimated $149K.
  • Occudo Quantitative Strategies first reported a position in Organogenesis Holdings in Q4 2020 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Organogenesis Holdings position peaked at $254K in Q2 2023.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.